Cresco Labs (CRLBF) Gains from Investment Securities (2020 - 2026)

Cresco Labs' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at -$341000.0 for Q1 2026.

• Quarterly Gains from Investment Securities changed N/A year-over-year to -$341000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $549000.0 (changed N/A YoY) and the FY2025 annual result came in at -$1.1 million, down 241.67% from the prior year.
• Gains from Investment Securities was -$341000.0 for Q1 2026 at Cresco Labs, down from $1.4 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $5.7 million in Q1 2022 and bottomed at -$488000.0 in Q2 2024.
• A 4-year average of $1.2 million and a median of $547000.0 in 2023 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2022 — Gains from Investment Securities tumbled 49.0% — and 2024, when it slumped 109.14%.
• Cresco Labs' Gains from Investment Securities stood at $5.7 million in 2022, then tumbled by 78.75% to $1.2 million in 2023, then rose by 14.45% to $1.4 million in 2024, then sank by 124.75% to -$341000.0 in 2026.
• Business Quant data shows CRLBF's Gains from Investment Securities at -$341000.0 in Q1 2026, $1.4 million in Q4 2024, and -$488000.0 in Q2 2024.